NCT05871684 2023-08-01
A Combination Study of CAR-T Therapy in r/r B-NHL
Ruijin Hospital
Phase 2 Unknown
Clinical Trials
5 trialsNCT05137886 2021-12-17
PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Unknown
NCT04539444 2021-08-02
A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT04419441 2020-09-16
ICI-RT-1
Ospedale Maggiore Di Trieste
Unknown
NCT03991559 2019-08-28
A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas
Chinese PLA General Hospital
Phase 1 Unknown